Author:
Jasińska-Stroschein Magdalena,Dymek Justyna,Drozd Mariola,Sierpniowska Olga,Jędra Artur,Stankiewicz Agnieszka,Stasiak Paulina,Cholewa Sylwia,Nowakowska Magdalena,Waszyk-Nowaczyk Magdalena
Abstract
AbstractBackground. The New Medicine Service (NMS) was developed in England more than ten years ago, as a three-stage consultation led by community pharmacists to support patients taking new medication for a chronic disease. In Poland, the scheme was officially introduced in January 2023. However, its implementation into common practice has been presented with various obstacles, including the need to develop relationships with general practitioners, resolve the payment structure, and provide training with adequate supporting materials. Hence, written materials have been designed for use as an optional tool for counselling patients receiving an NMS in community pharmacies. Methods. The present study evaluates the ability of these materials to inform patients about the need to adhere to anti-hypertensive medication. A group of 401 randomly-selected adult visitors to pharmacies and/or healthcare centres were surveyed; one third had hypertension in their history. Results. The structure, grammar and readability of the text achieved the required threshold of 40% according to the Plain Language Index. The designed materials effectively informed the patients about anti-hypertensive medication, reflected in an increased score in a knowledge test, and were rated positively regarding information level, comprehensibility and presentation. Conclusion. The proposed material may serve as an additional, “patient-friendly” educational tool for use as part of an NMS.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Elliott RA, Boyd MJ, Tanajewski L, Barber N, Gkountouras G, Avery AJ, et al. New medicine service’: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial. BMJ Qual Saf. 2020;29:286–95. https://doi.org/10.1136/bmjqs-2018-009177
2. Hovland R, Bremer S, Frigaard C, Henjum S, Faksvåg PK, Saether EM, et al. Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies. Int J Pharm Pract. 2020;28:337–45. https://doi.org/10.1111/ijpp.12598
3. Elliott RA, Boyd MJ, Salema NE, Davies J, Barber N, Mehta RL, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the new medicine service. BMJ Qual Saf. 2016;25:747–58. https://doi.org/10.1136/bmjqs-2015-004400
4. Waszyk-Nowaczyk M, Jasińska-Stroschein M, Drozd M, Dymek J, Stankiewicz A, Jędra A. Guidelines for performing new medical pharmaceutical service. Position of the team for the standardization of pharmaceutical care of the chamber of pharmacy and the Polish pharmaceutical society. Warszawa: Naczelna Izba Aptekarska; 2024, https://opiekafarmaceutyczna.nia.org.pl/ [Accessed 11 February 2024].
5. Waszyk-Nowaczyk M, Dymek J, Drozd M, Sierpniowska O, Stankiewicz A, Jędra A, et al. New medicine service as support for medication adherence by chronically ill patients. Farm Pol. 2023;79:281–8. https://doi.org/10.32383/farmpol/172894
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献